Skip to main content

Advertisement

ADVERTISEMENT

Volume 15 - Issue 8 - August, 2003

Feature

Original Contribution
03/14/2012

Ashraf M. Nagm, MD and John W. Moore, MD, MPH

Ashraf M. Nagm, MD and John W. Moore,...
NULL
NULL
NULL
03/14/2012
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Vitor O. Gomes, MD, Patrícia Blaya, MD, Carlos E. Poli de Figueiredo, MD, PhD, Waldomiro Manfroi, MD, PhD, Paulo Caramori, MD, PhD
Vitor O. Gomes, MD, Patrícia Blaya,...
(PART II of II) 7) Hemodialysis. Lehnert et al.,63 in a randomized study, assessed the prophylactic use of hemodialysis for 3 hours in patients with serum creatinine above 1.4 mg/dl who underwent both cardiac and non-cardiac procedures,...
(PART II of II) 7) Hemodialysis. Lehnert et al.,63 in a randomized study, assessed the prophylactic use of hemodialysis for 3 hours in patients with serum creatinine above 1.4 mg/dl who underwent both cardiac and non-cardiac procedures,...
(PART II of II) 7)...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Ping-Han Lo, MD, Jui-Sung Hung, MD, Kean-Wah Lau, MD, *Moo Hyun Kim, MD, †Po-Ming Ku, MD, §Mohammad Krayyem, MD
Ping-Han Lo, MD, Jui-Sung Hung, MD, K...
Double-orifice mitral valve (DOMV) is a rare congenital anomaly characterized by the presence of 2 mitral orifices, each possessing an independent chordal attachment to a papillary muscle.1,2 DOMV may occur as an isolated anomaly or, more...
Double-orifice mitral valve (DOMV) is a rare congenital anomaly characterized by the presence of 2 mitral orifices, each possessing an independent chordal attachment to a papillary muscle.1,2 DOMV may occur as an isolated anomaly or, more...
Double-orifice mitral valve...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
George M. Tadros, MD, *Elie N. Mouhayar, MD, *Akindolapo O. Akinwande, MD, *Brenda Campbell, RN, **Craig Wood, MS, *James C. Blankenship, MD, *Elias A. Iliadis, MD
George M. Tadros, MD, *Elie N. Mouhay...
Acute transient renal insufficiency after exposure to radiocontrast agents has been well described. The incidence varies among studies depending on the definition and the patient population studied.1 One of the more commonly accepted...
Acute transient renal insufficiency after exposure to radiocontrast agents has been well described. The incidence varies among studies depending on the definition and the patient population studied.1 One of the more commonly accepted...
Acute transient renal...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ehtisham Mahmud, MD, Kevin D. Shaw, BS, William F. Penny, MD
Ehtisham Mahmud, MD, Kevin D. Shaw, B...
Despite advances in the technical and pharmacologic aspects of percutaneous coronary intervention (PCI), periprocedural myocardial infarction (PPMI) remains a significant complication of the procedure. Previous studies identified clinical...
Despite advances in the technical and pharmacologic aspects of percutaneous coronary intervention (PCI), periprocedural myocardial infarction (PPMI) remains a significant complication of the procedure. Previous studies identified clinical...
Despite advances in the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Christiana M. Schannwell, MD, Markus Schneppenheim, MD, Gunnar Plehn, MD, Bodo E. Strauer, MD
Christiana M. Schannwell, MD, Markus...
Over the past 20 years, percutaneous transluminal coronary angioplasty (PTCA) has emerged as the treatment of choice for many patients with atherosclerotic coronary artery disease. With increased experience and technical advances, the...
Over the past 20 years, percutaneous transluminal coronary angioplasty (PTCA) has emerged as the treatment of choice for many patients with atherosclerotic coronary artery disease. With increased experience and technical advances, the...
Over the past 20 years,...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
David E. Allie, MD, Mitchell D. Lirtzman, MD, Charles H. Wyatt, MD, V. Antoine Keller, MD, Mohamed H. Khan, MD, Muhammad A. Khan, MD, Peter S. Fail, MD, Chris J. Hebert, RT, RCIS, Sonja D. Ellis, MBA, Elena Mitran, MD, Gary Chaisson, RT, RCIS, Samuel Stagg, Jr., MD, Adam A. Allie, MS, Craig M. Walker, MD
David E. Allie, MD, Mitchell D. Lirt...
Over 200,000 peripheral interventions were performed in 1997; this number continues to grow at a rapid pace.1 Peripheral artery disease (PAD), also referred to as peripheral vascular disease (PVD), affects 12–20% of Americans >= 65 years...
Over 200,000 peripheral interventions were performed in 1997; this number continues to grow at a rapid pace.1 Peripheral artery disease (PAD), also referred to as peripheral vascular disease (PVD), affects 12–20% of Americans >= 65 years...
Over 200,000 peripheral...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
08/01/2008
Joseph R. Carver, MD
Joseph R. Carver, MD
Contrast-induced nephropathy (CIN) is a well-recognized complication of angiographic procedures. The incidence varies according to the population studied, the definition applied and the vigilance of the angiographer in measuring post...
Contrast-induced nephropathy (CIN) is a well-recognized complication of angiographic procedures. The incidence varies according to the population studied, the definition applied and the vigilance of the angiographer in measuring post...
Contrast-induced nephropathy...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Fernando Boccalandro, MD and H. Vernon Anderson, MD
Fernando Boccalandro, MD and H. Verno...
Contrast-induced nephropathy (CIN) represents a significant clinical problem in the United States, where more than 1,000,000 patients undergo cardiac catheterization procedures every year. This makes catheterization the second most frequent...
Contrast-induced nephropathy (CIN) represents a significant clinical problem in the United States, where more than 1,000,000 patients undergo cardiac catheterization procedures every year. This makes catheterization the second most frequent...
Contrast-induced nephropathy...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Steven Goldberg, MD
Steven Goldberg, MD
After World War I, two independent companies named Bayer separately marketed the same compound with the trademarked name, Aspirin. This absurd scenario was well chronicled in the book, The Aspirin Wars, by Mann and Plummer.1 For the past...
After World War I, two independent companies named Bayer separately marketed the same compound with the trademarked name, Aspirin. This absurd scenario was well chronicled in the book, The Aspirin Wars, by Mann and Plummer.1 For the past...
After World War I, two...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement